Australia markets closed
  • ALL ORDS

    7,709.50
    +21.50 (+0.28%)
     
  • ASX 200

    7,493.80
    +25.50 (+0.34%)
     
  • AUD/USD

    0.7108
    -0.0009 (-0.13%)
     
  • OIL

    81.92
    +0.91 (+1.12%)
     
  • GOLD

    1,923.80
    -6.20 (-0.32%)
     
  • BTC-AUD

    32,271.59
    -547.01 (-1.67%)
     
  • CMC Crypto 200

    518.93
    +1.92 (+0.37%)
     
  • AUD/EUR

    0.6542
    +0.0013 (+0.20%)
     
  • AUD/NZD

    1.0961
    +0.0001 (+0.01%)
     
  • NZX 50

    12,036.05
    +12.59 (+0.10%)
     
  • NASDAQ

    12,038.39
    -13.09 (-0.11%)
     
  • FTSE

    7,763.49
    +2.38 (+0.03%)
     
  • Dow Jones

    33,972.29
    +22.88 (+0.07%)
     
  • DAX

    15,101.36
    -31.49 (-0.21%)
     
  • Hang Seng

    22,688.90
    +122.12 (+0.54%)
     
  • NIKKEI 225

    27,382.56
    +19.81 (+0.07%)
     

Better Dividend Stock: AbbVie or Viatris?

Better Dividend Stock: AbbVie or Viatris?

AbbVie (NYSE: ABBV) and Viatris (NASDAQ: VTRS) have a lot more in common than first glances would suggest. The two were both spun off from larger companies and now deliver above-average dividend yields. In AbbVie's case, it is the patent cliff next year for its immunology drug Humira, the top-selling drug last year other than COVID-19 vaccines.